Companies House does not verify the accuracy of the information filed

INTERCEPT PHARMA EUROPE LTD.

Company number 09224395

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
01 Oct 2024	CS01	Confirmation statement made on 30 September 2024 with updates	View PDF Confirmation statement made on 30 September 2024 with updates - link opens in a new window - 5 pages (5 pages)
25 Jul 2024	TM01	Termination of appointment of Kathleen Munster as a director on 24 July 2024	View PDF Termination of appointment of Kathleen Munster as a director on 24 July 2024 - link opens in a new window - 1 page (1 page)
30 Apr 2024	TM01	Termination of appointment of Graham Charles Higson as a director on 27 April 2024	View PDF Termination of appointment of Graham Charles Higson as a director on 27 April 2024 - link opens in a new window - 1 page (1 page)
17 Feb 2024	AA	Full accounts made up to 31 December 2022	View PDF Full accounts made up to 31 December 2022 - link opens in a new window - 46 pages (46 pages)
27 Nov 2023	TM01	Termination of appointment of Stephanie Rose Kenyon as a director on 23 November 2023	View PDF Termination of appointment of Stephanie Rose Kenyon as a director on 23 November 2023 - link opens in a new window - 1 page (1 page)
22 Nov 2023	TM01	Termination of appointment of David Ford as a director on 21 November 2023	View PDF Termination of appointment of David Ford as a director on 21 November 2023 - link opens in a new window - 1 page (1 page)
10 Nov 2023	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities	View PDF Resolutions RES10 ‐ Resolution of allotment of securities - link opens in a new window - 1 page (1 page)
06 Nov 2023	SH19	Statement of capital on 6 November 2023 GBP 1	View PDF Statement of capital on 6 November 2023 GBP 1 - link opens in a new window - 3 pages (3 pages)
06 Nov 2023	CAP-SS	Solvency Statement dated 03/11/23	View PDF Solvency Statement dated 03/11/23 - link opens in a new window - 6 pages (6 pages)
06 Nov 2023	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 6 pages (6 pages)
06 Nov 2023	RESOLUTIONS	Resolutions RES06 ‐ Resolution of reduction in issued share capital RES13 ‐ Cancellation of share premium account/amount credited to a reserve 03/11/2023	View PDF Resolutions RES06 ‐ Resolution of reduction in issued share capital RES13 ‐ Cancellation of share premium account/amount credited to a reserve 03/11/2023 - link opens in a new window - 1 page (1 page)
05 Nov 2023	SH01	Statement of capital following an allotment of shares on 3 November 2023 GBP 76,835,864	View PDF Statement of capital following an allotment of shares on 3 November 2023 GBP 76,835,864 - link opens in a new window - 7 pages (7 pages)
30 Oct 2023	CH01	Director's details changed for Rocco Venezia on 30 October 2023	View PDF Director's details changed for Rocco Venezia on 30 October 2023 - link opens in a new window - 2 pages (2 pages)
09 Oct 2023	CS01	Confirmation statement made on 30 September 2023 with updates	View PDF Confirmation statement made on 30 September 2023 with updates - link opens in a new window - 5 pages (5 pages)
03 Mar 2023	AA	Full accounts made up to 31 December 2021	View PDF Full accounts made up to 31 December 2021 - link opens in a new window - 47 pages (47 pages)
24 Jan 2023	AP01	Appointment of Mr Graham Higson as a director on 24 January 2023	View PDF Appointment of Mr Graham Higson as a director on 24 January 2023 - link opens in a new window - 2 pages (2 pages)
24 Jan 2023	AP01	Appointment of Ms Kathleen Munster as a director on 24 January 2023	View PDF Appointment of Ms Kathleen Munster as a director on 24 January 2023 - link opens in a new window - 2 pages (2 pages)
24 Jan 2023	AP01	Appointment of Ms Stephanie Rose Kenyon as a director on 24 January 2023	View PDF Appointment of Ms Stephanie Rose Kenyon as a director on 24 January 2023 - link opens in a new window - 2 pages (2 pages)
24 Jan 2023	AP01	Appointment of Mr David Ford as a director on 24 January 2023	View PDF Appointment of Mr David Ford as a director on 24 January 2023 - link opens in a new window - 2 pages (2 pages)
24 Jan 2023	TM01	Termination of appointment of Michael Gemellaro as a director on 24 January 2023	View PDF Termination of appointment of Michael Gemellaro as a director on 24 January 2023 - link opens in a new window - 1 page (1 page)
24 Jan 2023	TM01	Termination of appointment of Linda Richardson as a director on 24 January 2023	View PDF Termination of appointment of Linda Richardson as a director on 24 January 2023 - link opens in a new window - 1 page (1 page)
23 Dec 2022	SH01	Statement of capital following an allotment of shares on 22 December 2022 GBP 288	View PDF Statement of capital following an allotment of shares on 22 December 2022 GBP 288 - link opens in a new window - 8 pages (8 pages)
04 Oct 2022	CS01	Confirmation statement made on 30 September 2022 with updates	View PDF Confirmation statement made on 30 September 2022 with updates - link opens in a new window - 5 pages (5 pages)
26 Jul 2022	CH01	Director's details changed for Mr Michael Gemellaro on 26 July 2022	View PDF Director's details changed for Mr Michael Gemellaro on 26 July 2022 - link opens in a new window - 2 pages (2 pages)
26 Jul 2022	CH01	Director's details changed for Linda Richardson on 26 July 2022	View PDF Director's details changed for Linda Richardson on 26 July 2022 - link opens in a new window - 2 pages (2 pages)

Cookies on Companies House services

INTERCEPT PHARMA EUROPE LTD.

Filter by category